Expand Document | Expand Chapter | Full TOC | Printable HTML version
WHO Drug Information Vol. 14, No. 4, 2000
(2000; 78 pages) View the PDF document
Table of Contents
Open this folder and view contentsGeneral Policy Issues
Open this folder and view contentsVaccines and Biomedicines
Open this folder and view contentsGeneral Information
Open this folder and view contentsRegulatory and Safety Matters
View the documentATC/DDD Classification (final)
View the documentATC/DDD Classification (temporary)
Open this folder and view contentsHerbal Medicines
Open this folder and view contentsPublications and Sources of Information
 

ATC/DDD Classification (temporary)

The following temporary anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDDs) were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 23 and 24 October 2000. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no. If no objections are received, the new ATC codes and DDDs will be considered final and will be included in the January 2002 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy.

ATC level

INN/common name

ATC code

New ATC level codes (other than 5th level):

Drugs acting on serotonin receptors

 

A03AE

Prostaglandins

 

S01EE

Streptogramins

 

J01FG

New ATC 5th level codes:

 

alosetron

A03AE01

 

benzethoniumchloride, combinations

D08AJ58

 

betacarotene

A11CA02

 

betaine

A16AA06

 

betamethasone

S03BA03

 

biphenylol

D08AE06

 

bisacodyl,combinations

A06AB52

 

carglutamic acid

A16AA05

 

caspofungin

J02AX04

 

doxycycline

A01AB22

 

drospirenoneandestrogen

G03AA12

 

dyclonine

R02AD04

 

dydrogesteroneandestrogen

G03FA14

 

epinephrine

R01AA14

 

ethanol

D08AX08

 

indium (111In)capromabpendetide

V09IB04

 

ioxilan

V08AB12

 

iproclozide

N06AF06

 

levetiracetam

N03AX14

 

linezolid

J01XX08

 

lopinavir

J05AE06

 

magnesium citrate

A06AD19

 

magnesium oxide

A12CC10

 

nifenazone

M02AA24

 

peginterferon alfa-2a

L03AB11

 

phenol

R02AA19

 

pyrithione zinc

D11AX12

 

quinupristin/dalfopristin

J01FG02

 

rasburicase

V03AF07

 

tegaserod

A03AE02

 

tramadol, combinations

N02AX52

 

unoprostone

S01EE02

 

zoledronicacid

M05BA08

ATC code changes

Previous:

bupropion

N06AX12

New:

bupropion

N07BA02

Previous:

glatiramer acetate

L04AA07

New:

glatiramer acetate

L03AX13

Previous:

latanoprost

S01EX03

New:

latanoprost

S01EE01

Previous:

pristinamycin

J01FA04

New:

pristinamycin

J01FG01

Change of name:

Previous: Macrolidesandlincosamides

   

New: Macrolides, lincosamides and streptogramins

J01F

Previous:

amfebutamone

 

New:

bupropion

N07BA02

New DDDs:

INN/common name

DDD

Unit

Route of Administration

ATC code

alosetron*

2

mg

O

A03AE01

atosiban

165

mg

P

G02CX01

brinzolamide

0.2

ml

 

S01EC04

bupropion**

0.3

g

O

N07BA02

dihydrocodeine

0.15

g

O

N02AA08

esomeprazole

20

mg

O

A02BC05

etanercept

7

mg

P

L04AA11

infliximab

3.75

mg

P

L04AA12

levetiracetam*

2

g

O

N03AX14

levodropropizine

0.12

g

O

R05DB27

meloxicam

15

mg

P

M01AC06

nonacog alfa

1000

U

P

B02BD09

protionamide

0.75

g

O

J04AD01

quinupristin/dalfopristin*

1.5

g

P

J01FG02

rifampicin

0.6

g

P

J04AB02

ribavirine

1

g

O

J05AB04

zoledronic acid*

4

mg

P

M05BA08

* Temporary ATC code
** Temporary changed ATC code from N06AX12 to N07BA02

 

to previous section to next section
 

Last updated: May 3, 2013